03.07.2002
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
L.H. Lindholm, H. Ibsen, B. Dahlöf, R.B. Devereux, G. Beevers, U. de Faire, F. Fyhrquist, S. Julius, S.E. Kjeldsen, K. Kristiansson, O. Lederballe-Pedersen, M.S. Nieminen, P. Omvik, S. Oparil, H. Wedel, P. Aurup, J. Edelman, S. Snapinn, for the LIFE Study Group
The Lancet, 2002; 359: 1004-1010